IRIDEX (IRIX)
(Delayed Data from NSDQ)
$2.87 USD
-0.09 (-3.04%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $2.87 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth C Momentum D VGM
Price, Consensus and EPS Surprise
IRIX 2.87 -0.09(-3.04%)
Will IRIX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IRIX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IRIX
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
Zacks Industry Outlook Highlights MicroVision, Cutera and IRIDEX
IRIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Laser Systems Stocks to Watch in a Challenging Industry
IPG Photonics (IPGP) Q4 Earnings Miss Estimates
IPG Photonics (IPGP) Q3 Earnings Surpass Estimates
Other News for IRIX
Iridex's Strategic Review Process Should Bear Fruit 'Soon'
12 Health Care Stocks Moving In Thursday's After-Market Session
Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Iridex (IRIX) and Keros Therapeutics (KROS)
Iridex: Q4 Earnings Snapshot
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results